Quarterly Consolidated Statement Of Cash Flows

COSMO BIO COMPANY, LIMITED - Filing #7272352

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
359,000,000 JPY
865,000,000 JPY
Interest and dividends received
76,000,000 JPY
56,000,000 JPY
Interest paid
0 JPY
0 JPY
Net cash provided by (used in) operating activities
241,000,000 JPY
736,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-216,000,000 JPY
-67,000,000 JPY
Purchase of investment securities
-150,000,000 JPY
-700,000,000 JPY
Proceeds from sale of investment securities
53,000,000 JPY
JPY
Other, net
-1,000,000 JPY
1,000,000 JPY
Net cash provided by (used in) investing activities
-217,000,000 JPY
-758,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-144,000,000 JPY
0 JPY
Dividends paid
-175,000,000 JPY
-197,000,000 JPY
Dividends paid to non-controlling interests
-2,000,000 JPY
-2,000,000 JPY
Other, net
-1,000,000 JPY
-1,000,000 JPY
Net cash provided by (used in) financing activities
-479,000,000 JPY
-201,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
22,000,000 JPY
13,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-433,000,000 JPY
-210,000,000 JPY
Cash and cash equivalents
2,393,000,000 JPY
2,826,000,000 JPY
3,036,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.